Cbfa1 expression in vascular smooth muscle cells may be elevated by increased nitric oxide/iNOS
Open Access
- 1 September 2020
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Nephrology
- Vol. 42 (3) , 300-306
Abstract
Introduction: Vascular calcification is a common complication of chronic kidney disease. Osteoblast differentiation factor (Cbfa1) is present in histologic sections of arteries from patients with end-stage renal disease. Vascular smooth muscle cells (VSMC) can dedifferentiate to osteoblast-like cells, possibly by up-regulation of Cbfa1. There is evidence that the production of nitric oxide (NO) may have an important role in the regulation of osteoblast metabolism. The aim of this study is to evaluate whether increased NO/iNOS expression causes an increase in cbfa1 expression in VSMC. Methods: VSMC were obtained from renal artery of Wistar male rats, treated for 72 hours with lipopolysaccharide (LPS), ß-glycerophosphate (BGF), a donor of phosphate and aminoguanidine (AG), an inhibitor of iNOS, in the following groups: CTL (control), LPS, BGF, LPS + BGF, and LPS + AG. NO synthesis was determined by chemiluminescence. Cbfa1 and iNOS mRNA expressions were analyzed by RT-PCR, Cbfa1 protein expression by immunohistochemistry and cellular viability by acridine orange. Results: Cbfa1 and iNOS mRNA expressions were higher in LPS and LPS+ BGF vs CTL (p < 0.05), and they were lower in LPS+AG vs LPS (p < 0.05). The Cbfa1 in the groups LPS and LPS+BGF also resulted in a higher value compared to CTL (p < 0.05), and in LPS+AG it was lower compared to LPS (p < 0.05). NO was higher in LPS and LPS+BGF compared to CTL group (p < 0.05) and lower in LPS + AG compared to LPS group (p < 0.05). Cellular viability showed no statistical difference among groups. Conclusion: This study showed that increased NO/iNOS expression causes an increase in cbfa1 expression in VSMC.Keywords
This publication has 22 references indexed in Scilit:
- Pioglitazone Ameliorates Endothelial Dysfunction in Those with Impaired Glucose Regulation among the First-Degree Relatives of Type 2 Diabetes Mellitus PatientsMedical Principles and Practice, 2012
- Vascular Calcification in Patients with Chronic Kidney Disease: Types, Clinical Impact and PathogenesisMedical Principles and Practice, 2011
- Cbfa-1 mediates nitric oxide regulation of MMP-13 in osteoblastsJournal of Cell Science, 2006
- Vascular calcification in chronic kidney diseaseJournal of Bone and Mineral Metabolism, 2006
- Cyclosporine A and NAC on the inducible nitric oxide synthase expression and nitric oxide synthesis in rat renal artery cultured cellsKidney International, 2005
- Regulation of Vascular CalcificationCirculation Research, 2005
- Endothelial nitric oxide synthase in the control of osteoblastic mineralizing activity and bone integrityThe Journal of Pathology, 2004
- Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vesselsKidney International, 2003
- Multilineage Potential of Adult Human Mesenchymal Stem CellsScience, 1999
- Cloning and Characterization of Inducible Nitric Oxide Synthase from Mouse MacrophagesScience, 1992